Your browser doesn't support javascript.
loading
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin.
Bahrami, Nazli; Jabeen, Shakila; Tahiri, Andliena; Sauer, Torill; Ødegård, Hilde Presterud; Geisler, Stephanie Beate; Gravdehaug, Berit; Reitsma, Laurens Cornelus; Selsås, Knut; Kristensen, Vessela; Geisler, Jürgen.
Afiliación
  • Bahrami N; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
  • Jabeen S; Department of Breast and Endocrine Surgery, Akershus University Hospital, Lørenskog, Norway.
  • Tahiri A; Department of Clinical Molecular Biology (EPIGEN), Akershus University Hospital, Lørenskog, Norway.
  • Sauer T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Ødegård HP; Department of Clinical Molecular Biology (EPIGEN), Akershus University Hospital, Lørenskog, Norway.
  • Geisler SB; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Gravdehaug B; Department of Pathology, Akershus University Hospital, Lørenskog, Norway.
  • Reitsma LC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Selsås K; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
  • Kristensen V; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
  • Geisler J; Department of Breast and Endocrine Surgery, Akershus University Hospital, Lørenskog, Norway.
Breast Cancer Res Treat ; 190(3): 435-449, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34554372

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Inhibidores de la Aromatasa Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Noruega